Dubai, UAE — 21–23 October 2026 — Genèse Labs participated in AMWC Dubai 2026, held at Grand Hyatt Dubai, Exhibition Hall, from 21 to 23 October. Building on its participation in Dubai Derma in September, the company continued to strengthen its presence in the Middle East, presenting its professional aesthetic solutions to regional industry professionals and potential distribution partners. With a focus on SofistiCa, MESO PEPTA™ and Réluma Kiss, Genèse Labs highlighted its diverse portfolio of aesthetic solutions and continued its engagement with the region's evolving aesthetic-medicine market.

• Exhibition: AMWC Dubai 2026

• Dates and venue: 21–23 October 2026, Grand Hyatt Dubai, Dubai, UAE

• Key products: SofistiCa, MESO PEPTA™ and Réluma Kiss

AMWC Dubai brings together professionals from the field of aesthetic and anti-aging medicine, providing a platform for scientific exchange, industry networking and business development. Following its participation in Dubai Derma in September, Genèse Labs returned to Dubai to continue engaging with the regional aesthetic-medicine community. Participation in AMWC Dubai provided another opportunity to introduce the company's portfolio, connect with industry professionals and explore opportunities for future collaboration across the Middle East.

At AMWC Dubai, Genèse Labs highlighted three key product lines, reflecting its approach to addressing different needs within professional aesthetics. SofistiCa combines calcium hydroxyapatite (CaHA) and cross-linked hyaluronic acid (HA), bringing together two complementary components in a formulation developed for aesthetic applications. Réluma Kiss is an HA-based dermal filler specifically designed for lip enhancement, forming part of Genèse Labs' portfolio of targeted aesthetic solutions. MESO PEPTA™ Pink Code and Scalp Code represent the company's mesotherapy-focused approach to skin brightening and scalp care, respectively. Together, these products demonstrate the breadth of Genèse Labs' portfolio across injectable aesthetics and professional mesotherapy solutions.

International exhibitions play an important role in strengthening relationships with distributors, practitioners and other industry stakeholders. By participating in both Dubai Derma and AMWC Dubai, Genèse Labs continued its engagement with the Middle Eastern aesthetic-medicine market through two major industry events within a short period. The company's participation reflects its ongoing commitment to developing international distribution partnerships, expanding its global reach and introducing its professional aesthetic solutions to markets worldwide.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, fillers, neuromodulators, and longevity and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, SofistiCa, AxeniQ™, NADX³, Aqua Feel, MESO PEPTA™, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.